Mohamed A. Mahmoud

About

I am a pharmacology researcher. I earned my Master’s degree in Pharmacology from King Saud University. My thesis studied how pioglitazone can protect against colistin-induced kidney damage using bioinformatics tools and in vitro experimental approaches. I have also worked on projects in cancer, autism, multiple sclerosis, rheumatoid arthritis, lupus nephritis, and fulminant hepatic failure using in vitro and in vivo models. My goal is to study disease mechanisms, so I can devise novel approaches for disease diagnosis and treatment.

Work

King Saud University

|

Research Assistant

Saudi Arabia

→

Education

King Saud University

Saudi Arabia
→
Master of Sciences in Pharmacology

Ain Shams University

Egypt
→
Bachelor of Sciences in Pharmaceutical Sciences

Publications

The biological agent rituximab ameliorates DNA damage and repair efficiency in the somatic cells of arthritic mice

Electronic Journal of Biotechnology

journal-article

The PPAR-α selective agonist WY14643 improves lupus nephritis via the downregulation of the RORγT/STAT3 signaling pathway in MRL/lpr mice

International Immunopharmacology

journal-article

The PPAR-α selective agonist WY14643 improves lupus nephritis via the downregulation of the RORγT/STAT3 signaling pathway in MRL/lpr mice

International Immunopharmacology

journal-article

The PPAR-α selective agonist WY14643 improves lupus nephritis via the downregulation of the RORγT/STAT3 signaling pathway in MRL/lpr mice

International Immunopharmacology

journal-article

The ameliorative effect of pioglitazone against colistin-induced nephrotoxicity is mediated by inhibition of NF-κB and restoration of Nrf2 signaling: An integrative bioinformatics prediction-guided in vitro study

PLOS ONE

journal-article

The ameliorative effect of pioglitazone against colistin-induced nephrotoxicity is mediated by inhibition of NF-κB and restoration of Nrf2 signaling: An integrative bioinformatics prediction-guided in vitro study

PLoS ONE

journal-article

Salubrious effects of proanthocyanidins on behavioral phenotypes and DNA repair deficiency in the BTBR mouse model of autism

Saudi Pharmaceutical Journal

journal-article

Salubrious effects of proanthocyanidins on behavioral phenotypes and DNA repair deficiency in the BTBR mouse model of autism

Saudi Pharmaceutical Journal

journal-article

Aneugenic and clastogenic alterations in the DBA/IJ mouse model of rheumatoid arthritis treated with rituximab, an anti-CD20 antibody

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

journal-article

Aneugenic and clastogenic alterations in the DBA/IJ mouse model of rheumatoid arthritis treated with rituximab, an anti-CD20 antibody

Mutation Research/Genetic Toxicology and Environmental Mutagenesis

journal-article

Crosstalk of TNF-α, IFN-γ, NF-kB, STAT1 and redox signaling in lipopolysaccharide/D-galactosamine/dimethylsulfoxide-induced fulminant hepatic failure in mice

Saudi Pharmaceutical Journal

journal-article

Crosstalk of TNF-α, IFN-γ, NF-kB, STAT1 and redox signaling in lipopolysaccharide/d-galactosamine/dimethylsulfoxide-induced fulminant hepatic failure in mice

Saudi Pharmaceutical Journal

journal-article

Synthesis, anticancer activity and apoptosis induction of gold(I) complexes containing tris(o-methoxyphenyl)phosphane

Inorganica Chimica Acta

journal-article

Improved antimicrobial activity and oral bioavailability of delafloxacin by self-nanoemulsifying drug delivery system (SNEDDS)

Journal of Drug Delivery Science and Technology

journal-article

Methylmercury chloride exposure aggravates proinflammatory mediators and Notch-1 signaling in CD14+ and CD40+ cells and is associated with imbalance of neuroimmune function in BTBR T+ Itpr3tf/J mice

NeuroToxicology

journal-article

The MAP kinase inhibitor PD98059 reduces chromosomal instability in the autoimmune encephalomyelitis SJL/J-mouse model of multiple sclerosis

Mutation Research/Genetic Toxicology and Environmental Mutagenesis

journal-article